Well geez mate, though you can give us a head start if you have already done the math....
Sure, I'll find it and post here if you don't want to share.
All I'm saying is that ultimately the performance will determine if the product was acquired for cheap or expensive.
It is doesn't perform at all well then it's expensive no matter what you paid for it....
Austria? Is another pharma selling it there?
haha Richards problably don't yes!
Time will tell on how well our gNuvaring ( Myring ) will fare..... I mean if you have a reasonable theory based on other markets.... please share.
To say that we will drop to price to cost is not a reasonable theory....why even sell it then.
How does Fornieri feature in your mind?
Either the purchases and execution makes economic sense or they don't.
I'm not aware of any legal liability that involved Mayne.
Well geez mate, though you can give us a head start if you have...
-
- There are more pages in this discussion • 310 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.72 |
Change
0.040(0.85%) |
Mkt cap ! $401.5M | |||
| Open | High | Low | Value | Volume |
| $4.68 | $4.77 | $4.68 | $560.3K | 118.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 107 | $4.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.75 | 1500 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |